247 related articles for article (PubMed ID: 32422359)
1. The lipid homeostasis regulation study of arenobufagin in zebrafish HepG2 xenograft model and HepG2 cells using integrated lipidomics-proteomics approach.
Zhao LJ; Zhao HY; Wei XL; Guo FF; Wei JY; Wang HJ; Yang J; Yang ZG; Si N; Bian BL
J Ethnopharmacol; 2020 Oct; 260():112943. PubMed ID: 32422359
[TBL] [Abstract][Full Text] [Related]
2. 1β-OH-arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway.
Deng LJ; Lei YH; Quan JY; Li BJ; Zhang DM; Tian HY; Chen Y; Zhang EX; Chen L; Ye WC; Ning WM; Yu LZ; Liu JS
J Ethnopharmacol; 2021 Feb; 266():113443. PubMed ID: 33022344
[TBL] [Abstract][Full Text] [Related]
3. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
4. Research on anti-hepatocellular carcinoma activity and mechanism of Polygala fallax Hemsl.
Yao Z; Li Y; Wang Z; Lan Y; Zeng T; Gong H; Zhu K; Tang H; Gu S
J Ethnopharmacol; 2020 Oct; 260():113062. PubMed ID: 32512042
[TBL] [Abstract][Full Text] [Related]
5. Toxicokinetics of Arenobufagin and its Cardiotoxicity Mechanism Exploration Based on Lipidomics and Proteomics Approaches in Rats.
Zhao L; Han L; Wei X; Zhou Y; Zhang Y; Si N; Wang H; Yang J; Bian B; Zhao H
Front Pharmacol; 2021; 12():780016. PubMed ID: 35002716
[TBL] [Abstract][Full Text] [Related]
6. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
7. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
[TBL] [Abstract][Full Text] [Related]
8. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan Side-Chain Oxidase Enzyme Suppresses Hepatocellular Carcinoma Growth through Degradation of Tryptophan.
Ai Y; Wang B; Xiao S; Luo S; Wang Y
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830310
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy.
Miao Q; Bi LL; Li X; Miao S; Zhang J; Zhang S; Yang Q; Xie YH; Zhang J; Wang SW
Int J Mol Sci; 2013 Jan; 14(1):1370-82. PubMed ID: 23344047
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Proteomics Reveals That the Inhibition of Na(+)/K(+)-ATPase Activity Affects S-Phase Progression Leading to a Chromosome Segregation Disorder by Attenuating the Aurora A Function in Hepatocellular Carcinoma Cells.
Xu Z; Wang F; Fan F; Gu Y; Shan N; Meng X; Cheng S; Liu Y; Wang C; Song Y; Xu R
J Proteome Res; 2015 Nov; 14(11):4594-602. PubMed ID: 26491887
[TBL] [Abstract][Full Text] [Related]
12. Antitumor Efficacy of Huqizhengxiao (HQZX) Decoction Based on Inhibition of Telomerase Activity in Nude Mice of Hepatocarcinoma Xenograft.
Yu X; Lin XJ; Wang S; Liu X; Li W; Kou BX; Chai M; Chen D; Liu X; Wang X
Integr Cancer Ther; 2018 Dec; 17(4):1216-1224. PubMed ID: 29978739
[TBL] [Abstract][Full Text] [Related]
13. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling.
Zou M; Lu N; Hu C; Liu W; Sun Y; Wang X; You Q; Gu C; Xi T; Guo Q
Cell Signal; 2012 Aug; 24(8):1722-32. PubMed ID: 22560876
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice.
Jin Z; Jia BX; Tan LD; Chen QM; Liu YH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12368-12379. PubMed ID: 33336757
[TBL] [Abstract][Full Text] [Related]
15. A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling.
Yang AL; Wu Q; Hu ZD; Wang SP; Tao YF; Wang AM; Sun YX; Li XL; Dai L; Zhang J
Toxicol Appl Pharmacol; 2021 Nov; 431():115739. PubMed ID: 34619160
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatocellular carcinoma activity of Sorbaria sorbifolia by regulating VEGFR and c-Met/apoptotic pathway.
Xu ZH; Dang Y; Dong Y; Dong CY; Liu Y; Chen X; Yao Z; Shi JP
J Ethnopharmacol; 2024 Apr; 324():117758. PubMed ID: 38246481
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effects of the water-soluble total flavonoids from Isodon lophanthoides var.gerardianus (Benth.) H. Hara on apoptosis in HepG2 cell: Investigation of the most relevant mechanisms.
Feng CP; Tang HM; Huang S; Hou SZ; Liang J; Huang W; Lai XP
J Ethnopharmacol; 2016 Jul; 188():70-9. PubMed ID: 27132715
[TBL] [Abstract][Full Text] [Related]
18. Bufalin induces G2/M phase arrest and triggers autophagy via the TNF, JNK, BECN-1 and ATG8 pathway in human hepatoma cells.
Hsu CM; Tsai Y; Wan L; Tsai FJ
Int J Oncol; 2013 Jul; 43(1):338-48. PubMed ID: 23677253
[TBL] [Abstract][Full Text] [Related]
19. Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway.
Deng LJ; Peng QL; Wang LH; Xu J; Liu JS; Li YJ; Zhuo ZJ; Bai LL; Hu LP; Chen WM; Ye WC; Zhang DM
Oncotarget; 2015 Oct; 6(33):34258-75. PubMed ID: 26485758
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
Jeon YJ; Kim JS; Hwang GH; Wu Z; Han HJ; Park SH; Chang W; Kim LK; Lee YM; Liu KH; Lee MY
Eur J Pharmacol; 2015 Oct; 764():480-488. PubMed ID: 26209360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
